Slide Insurance (NASDAQ: SLDE) director exercises options and sells 5,000 shares

Q: What insider transactions did Slide Insurance (SLDE) director Stephen L. Rohde report?

Stephen L. Rohde exercised options for 5,000 Slide Insurance shares and sold 5,000 shares on July 31, 2026. The options covered 2,500 shares at 0.0018 and 2,500 shares at 1.3800 , with all shares sold at 20.0000 per share in the transaction.

Q: How many Slide Insurance (SLDE) shares did Stephen L. Rohde sell, and at what price?

Stephen L. Rohde sold 5,000 shares of Slide Insurance common stock at 20.0000 per share on July 31, 2026. These shares were obtained the same day through option exercises and then disposed of in a single reported sale transaction.

Q: Does the Slide Insurance (SLDE) Form 4 indicate trades under a Rule 10b5-1 plan?

No. The Form 4’s Rule 10b5-1 checkbox is not checked , and the footnotes do not reference any trading plan. The reported option exercises and 5,000-share sale therefore are not identified as being made under a Rule 10b5-1 plan.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Slide Insurance Holdings, Inc. director Stephen L. Rohde exercised stock options to acquire 5,000 shares of common stock and sold 5,000 shares on July 31, 2026.

The exercised options, which were fully vested and exercisable, covered 2,500 shares at 0.0018 per share and 2,500 shares at 1.3800 per share, and the sale price was 20.0000 per share.

Insider Trade Summary

Exercise and Sale: 5,000 shares ($97K approx. pre-tax spread)

Exercise and Sale 5 txns

Insider ROHDE STEPHEN L

Role Director

Sold 5,000 shs ($100K)

Approx. gross sale proceeds $100K

Approx. exercise cost $3K

Approx. pre-tax spread $97K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) ^F1	2,500	$0.00	$0.00
Exercise	Stock Option (Right to Buy) ^F1	2,500	$0.00	$0.00
Exercise	Common Stock	2,500	$0.0018	$4.50
Exercise	Common Stock	2,500	$1.38	$3K
Sale	Common Stock	5,000	$20.00	$100K

Holdings After Transaction: Stock Option (Right to Buy) — 52,500 shares (Direct); Common Stock — 0 shares (Direct)

Footnotes (1)

F1. These stock options are fully vested and exercisable.

Key Figures

Shares sold: 5,000 shares Sale price: 20.0000 per share Option exercise price 1: 0.0018 per share +2 more

5 metrics

Shares sold 5,000 shares Common stock sale on July 31, 2026

Sale price 20.0000 per share Price for 5,000 common shares sold on July 31, 2026

Option exercise price 1 0.0018 per share Stock option for 2,500 underlying shares expiring October 7, 2031

Option exercise price 2 1.3800 per share Stock option for 2,500 underlying shares expiring July 12, 2033

Shares from option exercises 5,000 shares Total underlying common shares acquired via option exercises on July 31, 2026

Key Terms

Stock Option (Right to Buy), derivative security, Sale in open market or private transaction

3 terms

Stock Option (Right to Buy) financial

"Reported security title: Stock Option (Right to Buy) for derivative entries"

derivative security financial

"Transaction described as Exercise or conversion of derivative security for options"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Sale in open market or private transaction financial

"Common stock sale transaction described as Sale in open market or private transaction"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/04/2026 - 04:54 PM Accepted by SEC EDGAR 08/04/2026 - 04:54 PM

FAQ

What insider transactions did Slide Insurance (SLDE) director Stephen L. Rohde report?

Stephen L. Rohde exercised options for 5,000 Slide Insurance shares and sold 5,000 shares on July 31, 2026. The options covered 2,500 shares at 0.0018 and 2,500 shares at 1.3800, with all shares sold at 20.0000 per share in the transaction.

How many Slide Insurance (SLDE) shares did Stephen L. Rohde sell, and at what price?

Stephen L. Rohde sold 5,000 shares of Slide Insurance common stock at 20.0000 per share on July 31, 2026. These shares were obtained the same day through option exercises and then disposed of in a single reported sale transaction.

What options did Stephen L. Rohde exercise in Slide Insurance (SLDE)?

He exercised two fully vested stock option grants covering a total of 5,000 shares of Slide Insurance common stock. One option covered 2,500 shares at an exercise price of 0.0018 per share, and the other covered 2,500 shares at 1.3800 per share.

Were the Slide Insurance (SLDE) options exercised by Stephen L. Rohde vested?

Yes. A footnote states that the reported Slide Insurance stock options were fully vested and exercisable when Stephen L. Rohde exercised them for 5,000 shares on July 31, 2026, before selling the acquired common shares the same day.

Does the Slide Insurance (SLDE) Form 4 indicate trades under a Rule 10b5-1 plan?

No. The Form 4’s Rule 10b5-1 checkbox is not checked, and the footnotes do not reference any trading plan. The reported option exercises and 5,000-share sale therefore are not identified as being made under a Rule 10b5-1 plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROHDE STEPHEN L

(Last)

(First)

(Middle)

C/O SLIDE INSURANCE HOLDINGS, INC.

4221 W. BOY SCOUT BLVD., SUITE 200

(Street)

TAMPA

FLORIDA

33607

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/31/2026		M		2,500	A	$0.0018	2,500	D
Common Stock	07/31/2026		M		2,500	A	$1.38	5,000	D
Common Stock	07/31/2026		S		5,000	D	$20	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$0.0018	07/31/2026		M			2,500	⁽¹⁾	10/07/2031	Common Stock	2,500	$0	0	D
Stock Option (Right to Buy)	$1.38	07/31/2026		M			2,500	⁽¹⁾	07/12/2033	Common Stock	2,500	$0	52,500	D

Explanation of Responses:

1. These stock options are fully vested and exercisable.

	/s/ Stephen Rohde	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR